Psychopharmacology

, Volume 108, Issue 4, pp 507–511 | Cite as

Nicotine intake and dependence in Swedish snuff takers

  • Herman Holm
  • Martin J. Jarvis
  • Michael A. H. Russell
  • Colin Feyerabend
Original Investigations

Abstract

Two studies examining nicotine intake in users of Swedish moist oral snuff are reported. Absorption form a single pinch (2 g) in ten users after overnight abstinence was fairly rapid. The increment in plasma nicotine concentrations averaged 9.9 ng/ml (SD 6.5) after 10 min and peaked at 14.5 ng/ml (SD 4.6) shortly after discarding at 30 min. Among groups of habitual snuff takers (n=27) and cigarette smokers (n=35) studied on a day of normal snuffing/smoking, peak blood nicotine levels after use were similar [averaging 36.6 ng/ml (SD 14.4) and 36.7 ng/ml (SD 16.1), respectively], but there was a tendency to higher cotinine levels in the snuffers (399.2 ng/ml versus 306.3 ng/ml). The snuff takers and cigarette smokers reported similar levels of subjective dependence on tobacco. Epidemiological study of Swedish snuff users could clarify whether the cardiovascular risks of tobacco are attributable to nicotine or to other smoke components, as in their case nicotine intake is not accompanied by combustion products.

Key words

Snuff Nicotine Cotinine Dependence 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Benowitz NL (1988) Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 319:1318–1330Google Scholar
  2. Benowitz NL, Porchet H, Sheiner L, Jacob P (1988) Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 44:23–28Google Scholar
  3. Feyerabend C, Russell MAH (1990) A rapid gas-liquid chromatographic method for the determination of nicotine and cotinine in biological fluids. J Pharm Pharmacol 42:450–452Google Scholar
  4. Gritz ER, Baer-Weiss V, Benowitz NL, Van Vunakis H, Jarvik M (1981) Plasma nicotine and cotinine concentrations in habitual smokeless tobacco users. Clin Pharmacol Ther 30:201–209Google Scholar
  5. Hatsukami DK (1991) Smokeless tobacco: current status and future directions. Br J Addict 86:559–563Google Scholar
  6. Hatsukami DK, Gust SW, Keenan RM (1987) Physiologic and subjective changes from smokeless tobacco withdrawal. Clin Pharmacol Ther 41:103–107Google Scholar
  7. Isaac PF, Rand MJ (1969) Blood levels of nicotine and physiological effects after inhalation of tobacco smoke. Eur J Pharmacol 8:269–283Google Scholar
  8. Keenan RM, Hatsukami DK, Anton DJ (1989) The effects of short-term smokeless tobacco deprivation on performance. Psychopharmacology 98:126–130Google Scholar
  9. Nordgren P, Ramstrom L (1990) Moist snuff in Sweden — tradition and evolution. Br J Addict 85:1107–1112Google Scholar
  10. Rand MJ (1989) Neuropharmacological effects of nicotine in relation to cholinergic mechanisms. In: Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds) Progress in brain research 79:3–11. Elsevier, AmsterdamGoogle Scholar
  11. Russell MAH (1988) Nicotine replacement: the role of blood nicotine levels, their rate of change, and nicotine tolerance. In: Pomerleau OF, Pomerleau CS (eds) Nicotine replacement: a critical evaluation. Liss, New York, pp 63–94Google Scholar
  12. Russell MAH, Jarvis MJ, Feyerabend C (1980) A new age for snuff? Lancet 1:474–475Google Scholar
  13. Russell MAH, Jarvis MJ, Devitt G, Feyerabend C (1981) Nicotine intake by snuff users. Br Med J 283:814–817Google Scholar
  14. Russell MAH, Jarvis MJ, Feyerabend C, Saloojee Y (1986) Reduction of tar, nicotine and carbon monoxide intake in low tar smokers. J Epidemiol Commun Health 40:80–85Google Scholar
  15. Squires WG, Brandon TA, Zingrat S, et al. (1984) Hemodynamic effects of oral smokeless tobacco in dogs and young adults. Prev Med 13:195–206Google Scholar
  16. US Department of Health and Human Services (1986) The health consequences of using smokeless tobacco: a report of the Surgeon General. USDHSS, Public Health Service, BethesdaGoogle Scholar
  17. US Department of Health and Human Services (1988) Nicotine addiction: a report of the Surgeon General. USDHHS, Public Health Service, MarylandGoogle Scholar
  18. Wald NJ, Idle M, Boreham J, Bailey A, Van Vunakis H (1984) Urinary nicotine concentrations in cigarette and pipe smokers. Thorax 39:365–368Google Scholar
  19. West R, Krafona K (1990) Oral tobacco: prevalence, health risks, dependence potential and public policy. Br J Addict 85:1097–1098Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Herman Holm
    • 1
  • Martin J. Jarvis
    • 2
  • Michael A. H. Russell
    • 2
  • Colin Feyerabend
    • 3
  1. 1.Department of PsychiatryKalmar HospitalS-KalmarSweden
  2. 2.ICRF Health Behaviour UnitInstitute of PsychiatryLondonUK
  3. 3.Poisons UnitNew Cross HospitalLondonUK

Personalised recommendations